Coexistence of the loss of heterozygosity at the PTEN locus and HER2 overexpression enhances the Akt activity thus leading to a negative progesterone receptor expression in breast carcinoma Eriko TokunagaEiji OkiYoshihiko Maehara Preclinical study 28 September 2006 Pages: 249 - 257
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis Kejin WuZhiwei QuanY. Eric Shi PRECLINICAL STUDY 04 July 2006 Pages: 259 - 267
Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers Eunsil YuYeon Sun AhnJene Choi Preclinical Study 09 August 2006 Pages: 269 - 278
Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis Mario R. D’AndreaMaria R. LimitiPietro L. Mingazzini Clinical Trial 12 July 2006 Pages: 279 - 284
Long-Term Management of Breast Cancer-Related Lymphedema after Intensive Decongestive Physiotherapy Stéphane VignesRaphaël PorcherAlain Dupuy Clinical trial 07 July 2006 Pages: 285 - 290
Accuracy and Underestimation of Malignancy of Breast Core Needle Biopsy: the Florence Experience of Over 4000 Consecutive Biopsies Stefano CiattoNehmat HoussamiGabriella G. Risso Epidemiology 06 July 2006 Pages: 291 - 297
Differential Roles of Angiotensinogen and Angiotensin Receptor type 1 Polymorphisms in Breast Cancer Risk A. M. González-Zuloeta LaddA. Arias VásquezC. M. van Duijn Epidemiology 06 July 2006 Pages: 299 - 304
Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers Asako OoeKikuya KatoShinzaburo Noguchi Epidemiology 05 July 2006 Pages: 305 - 315
Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer Hongyu WuKangmin ZhuJohn Potter Epidemiology 04 July 2006 Pages: 317 - 324
Cost-utility of adjuvant hormone therapies for breast cancer in post-menopausal women: sequential tamoxifen-exemestane and upfront anastrozole C. SkedgelD. RaysonT. Younis Epidemiology 02 August 2006 Pages: 325 - 333
The management of ductal carcinoma in situ of the breast: a screened population-based analysis Eileen RakovitchJean-Philippe PignolLawrence Paszat Epidemiology 13 July 2006 Pages: 335 - 347
Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature Alberto LuiniMarisel AguilarGiuseppe Viale REVIEW 29 September 2006 Pages: 349 - 353
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer Giampietro GaspariniMassimo GionDino Amadori Original Paper 19 July 2006 Pages: 355 - 365